Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis.
Paniagua RT, Sharpe O, Ho PP, Chan SM, Chang A, Higgins JP, Tomooka BH, Thomas FM, Song JJ, Goodman SB, Lee DM, Genovese MC, Utz PJ, Steinman L, Robinson WH.
Paniagua RT, et al. Among authors: sharpe o.
J Clin Invest. 2006 Oct;116(10):2633-42. doi: 10.1172/JCI28546. Epub 2006 Sep 14.
J Clin Invest. 2006.
PMID: 16981009
Free PMC article.